Cargando…
Biochemical Intracystic Biomarkers in the Differential Diagnosis of Pancreatic Cystic Lesions
Background and Objectives: Pancreatic cystic lesions (PCLs) are frequently incidental findings. The prevalence of PCLs is increasing, mainly due to advancements in imaging techniques, but also because of the aging of the population. PCLs comprise challenging clinical problems, as their manifestation...
Autores principales: | Wietrzykowska-Grishanovich, Dominika, Pawlik, Ewa, Neubauer, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331360/ https://www.ncbi.nlm.nih.gov/pubmed/35893110 http://dx.doi.org/10.3390/medicina58080994 |
Ejemplares similares
-
Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022) -
Differential Diagnosis of Cystic Pancreatic Lesions Including the Usefulness of Biomarkers
por: Lévy, Philippe, et al.
Publicado: (2015) -
Intracystic Therapies for Cystic Craniopharyngioma in Childhood
por: Bartels, Ute, et al.
Publicado: (2012) -
Radiomics for the Diagnosis and Differentiation of Pancreatic Cystic Lesions
por: Machicado, Jorge D., et al.
Publicado: (2020) -
Advances in the Diagnosis of Pancreatic Cystic Lesions
por: Pușcașu, Claudia Irina, et al.
Publicado: (2022)